CEN Biotech, Inc. (CENBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 29, 2025, 9:30 AM EDT
CEN Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2013 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2013 - 2016 |
| Cash & Equivalents | 0.15 | 0.19 | 0 | 0 | 0 | 0.08 | Upgrade
|
| Cash & Short-Term Investments | 0.15 | 0.19 | 0 | 0 | 0 | 0.08 | Upgrade
|
| Cash Growth | -30.71% | 10025.68% | -49.21% | 17.66% | -96.24% | 36.22% | Upgrade
|
| Accounts Receivable | 0.01 | 0.19 | - | - | - | - | Upgrade
|
| Other Receivables | 0.03 | 0.04 | - | - | - | - | Upgrade
|
| Receivables | 0.05 | 0.23 | 0.02 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.11 | 0.05 | - | - | - | - | Upgrade
|
| Total Current Assets | 0.3 | 0.47 | 0.02 | 0 | 0 | 0.08 | Upgrade
|
| Property, Plant & Equipment | 0.16 | 0.24 | - | 0.38 | 0.17 | 1.45 | Upgrade
|
| Goodwill | 1.28 | 1.31 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 4.82 | 5.07 | 4.96 | 5.38 | 5.81 | 6.23 | Upgrade
|
| Long-Term Deferred Tax Assets | 0 | 0 | - | - | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.22 | Upgrade
|
| Other Long-Term Assets | 1.3 | 1.3 | 1.29 | 1.49 | 1.29 | 1 | Upgrade
|
| Total Assets | 7.91 | 8.44 | 6.31 | 7.3 | 7.31 | 9.02 | Upgrade
|
| Accounts Payable | 0.45 | 0.54 | 0.2 | 0.18 | 0.21 | 0.09 | Upgrade
|
| Accrued Expenses | 3.81 | 3.87 | 3.38 | 11.43 | 8.21 | 5.44 | Upgrade
|
| Short-Term Debt | 3.25 | 3.25 | 1.62 | 11.2 | 11.14 | 10.86 | Upgrade
|
| Current Portion of Long-Term Debt | 2.06 | 1.94 | 9.48 | 8.01 | 4.85 | 3.63 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.1 | 0.02 | 0.04 | - | - | Upgrade
|
| Current Unearned Revenue | 0.14 | 0.15 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 9.83 | 9.86 | 14.71 | 30.87 | 24.41 | 20.03 | Upgrade
|
| Long-Term Debt | 0.03 | 0.03 | 0.08 | 1.06 | 3.16 | 3.01 | Upgrade
|
| Long-Term Leases | 0.16 | 0.21 | 0.14 | 0.18 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.38 | 0.72 | 1.01 | 5 | Upgrade
|
| Total Liabilities | 10.02 | 10.1 | 16.31 | 32.83 | 28.58 | 28.04 | Upgrade
|
| Additional Paid-In Capital | 44.92 | 44.34 | 17.07 | 15.78 | 14.39 | 9.11 | Upgrade
|
| Retained Earnings | -46.99 | -45.96 | -27.06 | -41.31 | -35.66 | -28.12 | Upgrade
|
| Comprehensive Income & Other | -0.04 | -0.03 | - | - | - | - | Upgrade
|
| Total Common Equity | -2.11 | -1.66 | -9.99 | -25.54 | -21.26 | -19.01 | Upgrade
|
| Shareholders' Equity | -2.11 | -1.66 | -9.99 | -25.54 | -21.26 | -19.01 | Upgrade
|
| Total Liabilities & Equity | 7.91 | 8.44 | 6.31 | 7.3 | 7.31 | 9.02 | Upgrade
|
| Total Debt | 5.62 | 5.54 | 11.34 | 20.5 | 19.15 | 17.5 | Upgrade
|
| Net Cash (Debt) | -5.47 | -5.35 | -11.34 | -20.49 | -19.15 | -17.42 | Upgrade
|
| Net Cash Per Share | -0.09 | -0.13 | -0.35 | -0.78 | -0.76 | -2.07 | Upgrade
|
| Filing Date Shares Outstanding | 64.13 | 56.41 | 27.59 | 27.01 | 25.52 | 25.13 | Upgrade
|
| Total Common Shares Outstanding | 63.99 | 55.96 | 27.56 | 26.95 | 25.47 | 25.13 | Upgrade
|
| Working Capital | -9.53 | -9.39 | -14.69 | -30.86 | -24.4 | -19.94 | Upgrade
|
| Book Value Per Share | -0.03 | -0.03 | -0.36 | -0.95 | -0.83 | -0.76 | Upgrade
|
| Tangible Book Value | -8.2 | -8.04 | -14.95 | -30.92 | -27.07 | -25.25 | Upgrade
|
| Tangible Book Value Per Share | -0.13 | -0.14 | -0.54 | -1.15 | -1.06 | -1.00 | Upgrade
|
| Machinery | - | 0.1 | - | 0.02 | 0.02 | 0.02 | Upgrade
|
| Leasehold Improvements | - | 0.02 | - | 0.17 | 0.17 | 1.43 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.